LINKLOGIS–W (09959.HK): H1 Revenue RMB 579mn, Up 54.6%; Attributable Profit RMB 24mn Turns to Profit
NewTimeSpace News: On 23 September 2026, Linklogis Inc. (the "Company") published its interim report for the six months ended 30 June 2026. Revenue and income from principal businesses amounted to approximately RMB 579.1 million (RMB 579,050 thousand), up about 54.6% from RMB 374.5 million (RMB 374,506 thousand) a year earlier; gross profit was about RMB 262.6 million (RMB 262,571 thousand), up about 25.1% year on year; and profit attributable to the Company's equity shareholders was about RMB 23.9 million (RMB 23,936 thousand) against a loss of RMB 379.7 million (RMB 379,727 thousand) a year earlier, turning to profit.
The announcement disclosed that by segment, revenue from the industrial fintech solutions was RMB 494.7 million (RMB 494,716 thousand), up about 51.1%; the treasury solutions for industry-finance was RMB 51.7 million (RMB 51,677 thousand), up about 145.9%; and the cross-border and international business solutions was RMB 32.7 million (RMB 32,657 thousand), up about 24.8%. On a non-IFRS basis, adjusted profit for the period was about RMB 15.6 million (RMB 15,603 thousand) against an adjusted loss of RMB 367.2 million (RMB 367,160 thousand) a year earlier, also turning to profit; adjusted profit margin shifted from -98.0% to 2.7%.
The Company stated that gross margin fell from 56.0% to 45.3%, mainly due to changes in business mix and the reclassification of revenue following the strategic upgrade. As the "AI + industrial finance" strategy deepened, the Group upgraded its former core-enterprise cloud and financial-institution cloud into the industrial fintech solutions and the treasury solutions for industry-finance.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- UBTECH ROBOTICS (09880.HK): Files CSRC Filing for H-share Full Circulation; 17.6m Shares to Convert
- SUNSHINE PHARMA (06887.HK): Files CSRC Filing for H-share Full Circulation; 38.9m Domestic Shares to Convert
- JINYUAN HCHEM (02502.HK): H1 Revenue RMB 1.54bn, Up 7.0%; Profit RMB 41.6mn Turns to Profit
- GENCH EDU (01525.HK): Independent Non-exec Director Changes; Shi & Zhang Appointed, Chen & Liu Resigned
- CENTRALCHINA MT (09982.HK): Proposes Renaming to Centric Cogni Mgmt Tech Group, Pivoting to Tech